Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
about
Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis.Two years of growth hormone treatment in the first growth hormone deficient patient with cerebrofaciothoracic dysplasia.Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia.
P2860
Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Present status of the use of g ...... es (diseases of the skeleton).
@ast
Present status of the use of g ...... es (diseases of the skeleton).
@en
Present status of the use of growth hormone in short children with bone diseases
@nl
type
label
Present status of the use of g ...... es (diseases of the skeleton).
@ast
Present status of the use of g ...... es (diseases of the skeleton).
@en
Present status of the use of growth hormone in short children with bone diseases
@nl
prefLabel
Present status of the use of g ...... es (diseases of the skeleton).
@ast
Present status of the use of g ...... es (diseases of the skeleton).
@en
Present status of the use of growth hormone in short children with bone diseases
@nl
P2860
P1476
Present status of the use of g ...... es (diseases of the skeleton).
@en
P2093
Kanaka-Gantenbein C
P2860
P356
10.1515/JPEM.2001.14.1.17
P577
2001-01-01T00:00:00Z